People
Ronald van Rij
Ronald van Rij associate professor
Ronald van Rij is associate professor at the Dept. of Medical Microbiology. He obtained his PhD Cum Laude from the University of Amsterdam.
read moreRonald van Rij associate professor
Ronald van Rij is associate professor and head of the laboratory of Experimental Virology at the Dept. of Medical Microbiology. As a PhD student, he studied chemokine receptors in HIV-1 infection and AIDS pathogenesis and obtained his PhD with honors (Cum Laude) from the University of Amsterdam. After post-doctoral training at the University of California San Francisco (USA) and the Hubrecht Institute (Utrecht, the Netherlands), he moved to Nijmegen as a recipient of a Radboudumc tenure-track fellowship. His laboratory studies virus-host interactions in insects and mammals. Current research is funded by several national and international grants, including a Consolidator Grant from the European Research Council (ERC), a VICI grant from the Netherlands Organization for Scientific Research (NWO), and a research grant from the Human Frontiers Science Program.
Personal prizes & awards National & international
- 2017: VICI fellowship, Netherlands Organization for Scientific Research (NWO)
- 2014: Consolidator grant, European Research Council (ERC)
Personal prizes & awards National & international
- 2017: VICI fellowship, Netherlands Organization for Scientific Research (NWO)
- 2014: Consolidator grant, European Research Council (ERC)
- 2010: Kluyver Award, Netherlands Society for Microbiology
- 2008: VIDI fellowship, Netherlands Organization for Scientific Research (NWO)
Field of study
Medical Microbiology
Radboud Institute for Molecular Life Sciences
Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more
Research group Experimental virology
Ronald van Rij's group studies virus-host interactions in both mosquito vector and mammalian host. By doing so, we hope to gain insights into arbovirus transmission and contribute to the development of novel antiviral therapy.
read more